» Articles » PMID: 18474760

Factors Associated with Longer Time from Symptom Onset to Hospital Presentation for Patients with ST-elevation Myocardial Infarction

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2008 May 14
PMID 18474760
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies have demonstrated the effects of single factors, such as age, sex, and race, with longer delays from symptom onset to hospital presentation in patients with ST-elevation myocardial infarction.

Methods: We studied risk factors individually and in combination to determine the cumulative effect on delay times in 482,327 patients with ST-elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction between January 1, 1995, and December 31, 2004. We analyzed patient subgroups with the following risk factors in combination: younger than 70 years vs 70 years and older, race/ethnicity, men vs women, and nondiabetic vs diabetic.

Results: The geometric mean for delay time was 114 minutes, with a decreasing trend from 123 minutes in 1995 to 113 minutes in 2004 (P < .001). Nearly half of the patients (45.5%) presented more than 2 hours and 8.7% presented more than 12 hours after the onset of symptoms. Compared with the reference group (those < 70 years, men, white, and did not have diabetes mellitus [DM]), subgroups with longer delay times (P < .01 for all) included those younger than 70 years, men, black, and had DM (+43 minutes); those younger than 70 years, women, black, and had DM (+55 minutes); those 70 years and older, men, black, and had DM (+60 minutes); and those 70 years and older, women, black, and had DM (+63 minutes).

Conclusions: Patient subgroups with a combination of factors (older age, women, Hispanic or black race, and DM) have particularly long delay times that may be 60 minutes longer than subgroups without those characteristics. Improving patient responsiveness in these subgroups represents an important opportunity to improve quality of care and minimize disparities in care.

Citing Articles

Major Delay in Door-to-Ballon Time for Primary Percutaneous Coronary Intervention is Not Related to Interventional Cardiologist's Late Arrival.

Movahed M, Irilouzadian R Int J Angiol. 2025; 34(1):44-50.

PMID: 39944142 PMC: 11813602. DOI: 10.1055/s-0044-1788279.


The ACCEPT Study and the Management of Ischemic Myocardial Disease in Brazil: Challenges and Opportunities in a Continental Country.

Bianco H Arq Bras Cardiol. 2024; 121(11):e20240604.

PMID: 39661804 PMC: 11634297. DOI: 10.36660/abc.20240604.


The impact of admission modes on the treatment outcome and in-hospital mortality rate of STEMI patients undergoing PPCI.

Wang Q, Zan C, Li F, Li Y, Wang F, Wang T Sci Rep. 2024; 14(1):18932.

PMID: 39147798 PMC: 11327245. DOI: 10.1038/s41598-024-68025-2.


Self-Administration of Aspirin After Chest Pain for the Prevention of Premature Cardiovascular Mortality in the United States: A Population-Based Analysis.

Russo R, Wikler D, Rahimi K, Danaei G J Am Heart Assoc. 2024; 13(11):e032778.

PMID: 38690705 PMC: 11255618. DOI: 10.1161/JAHA.123.032778.


Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation.

Kim Y, Her A, Rha S, Choi C, Choi B, Kim J Sci Rep. 2023; 13(1):16067.

PMID: 37752278 PMC: 10522700. DOI: 10.1038/s41598-023-43385-3.


References
1.
Bradley E, Herrin J, Wang Y, Barton B, Webster T, Mattera J . Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006; 355(22):2308-20. DOI: 10.1056/NEJMsa063117. View

2.
Goldberg R, Mooradd M, Gurwitz J, Rogers W, French W, Barron H . Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). Am J Cardiol. 1998; 82(3):259-64. DOI: 10.1016/s0002-9149(98)00342-7. View

3.
Nallamothu B, Bates E, Herrin J, Wang Y, Bradley E, Krumholz H . Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005; 111(6):761-7. DOI: 10.1161/01.CIR.0000155258.44268.F8. View

4.
Cannon C, Gibson C, LAMBREW C, Shoultz D, Levy D, French W . Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283(22):2941-7. DOI: 10.1001/jama.283.22.2941. View

5.
Magid D, Wang Y, Herrin J, McNamara R, Bradley E, Curtis J . Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA. 2005; 294(7):803-12. DOI: 10.1001/jama.294.7.803. View